These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 21814597

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Mutational spectrum and classification of novel mutations in patients with metastatic gastrointestinal stromal tumours.
    Bombac A, Zakotnik B, Bucic M, Setrajcic Dragos V, Gazic B, Stegel V, Klancar G, Novakovic S.
    Int J Oncol; 2020 Jun; 56(6):1468-1478. PubMed ID: 32236636
    [Abstract] [Full Text] [Related]

  • 26. A KIT-negative, DOG1-positive epithelioid GIST of the stomach harboring a novel PDGFRA exon 14 single nucleotide deletion.
    Rizzardi C, Marzinotto S, Avellini C, Melato M, Mariuzzi L.
    Anticancer Res; 2012 May; 32(5):1775-8. PubMed ID: 22593460
    [Abstract] [Full Text] [Related]

  • 27. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.
    Miettinen M, Lasota J.
    Arch Pathol Lab Med; 2006 Oct; 130(10):1466-78. PubMed ID: 17090188
    [Abstract] [Full Text] [Related]

  • 28. Molecular and Immunohistochemical Study of Platelet Derived Growth Factor Receptor Alpha in KIT Negative Gastrointestinal Stromal Tumors; the First Report from Iran.
    Geramizadeh B, Jowkar Z, Mousavi SJ.
    Middle East J Dig Dis; 2016 Jul; 8(3):226-231. PubMed ID: 27698973
    [Abstract] [Full Text] [Related]

  • 29. C-KIT and PDGFRA zygosity in gastrointestinal stromal tumors: Correlation with tumor site, tumor size, exon, and CD117 immunohistochemistry.
    Wallander ML, Willmore-Payne C, Layfield LJ.
    Appl Immunohistochem Mol Morphol; 2011 Jan; 19(1):21-7. PubMed ID: 20823768
    [Abstract] [Full Text] [Related]

  • 30. [Status and clinical implication of c-kit and PDGFRA mutations in 165 cases of gastrointestinal stromal tumor (GIST)].
    He HY, Fang WG, Zhong HH, Li Y, Zheng J, Du J, Heng WJ, Wu BQ.
    Zhonghua Bing Li Xue Za Zhi; 2006 May; 35(5):262-6. PubMed ID: 16776995
    [Abstract] [Full Text] [Related]

  • 31. KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs).
    Lasota J, Miettinen M.
    Semin Diagn Pathol; 2006 May; 23(2):91-102. PubMed ID: 17193822
    [Abstract] [Full Text] [Related]

  • 32. [Clinicopathological features and prognosis of 59 patients with platelet-derived growth factor α-mutant gastrointestinal stromal tumor].
    Sun XF, Gao XD, Yuan W, Sun JY, Fu M, Xue AW, Li H, Shu P, Fang Y, Hou YY, Shen KT, Sun YH, Qin J, Qin XY.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep 25; 23(9):880-887. PubMed ID: 32927513
    [Abstract] [Full Text] [Related]

  • 33. Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.
    Hayashi Y, Bardsley MR, Toyomasu Y, Milosavljevic S, Gajdos GB, Choi KM, Reid-Lombardo KM, Kendrick ML, Bingener-Casey J, Tang CM, Sicklick JK, Gibbons SJ, Farrugia G, Taguchi T, Gupta A, Rubin BP, Fletcher JA, Ramachandran A, Ordog T.
    Gastroenterology; 2015 Aug 25; 149(2):420-32.e16. PubMed ID: 25865047
    [Abstract] [Full Text] [Related]

  • 34. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
    Miettinen M, Sobin LH, Lasota J.
    Am J Surg Pathol; 2009 Sep 25; 33(9):1267-75. PubMed ID: 19440146
    [Abstract] [Full Text] [Related]

  • 35. Contribution of DOG1 expression to the diagnosis of gastrointestinal stromal tumors.
    Kara T, Serinsoz E, Arpaci RB, Gubur O, Orekici G, Ata A, Colak T, Arican A.
    Pathol Res Pract; 2013 Jul 25; 209(7):413-7. PubMed ID: 23722018
    [Abstract] [Full Text] [Related]

  • 36. DOG1 for the diagnosis of gastrointestinal stromal tumor (GIST): Comparison between 2 different antibodies.
    Lopes LF, West RB, Bacchi LM, van de Rijn M, Bacchi CE.
    Appl Immunohistochem Mol Morphol; 2010 Jul 25; 18(4):333-7. PubMed ID: 20571340
    [Abstract] [Full Text] [Related]

  • 37. Gastrointestinal stromal tumors (GISTs): CD117, DOG-1 and PKCθ expression. Is there any advantage in using several markers?
    Ríos-Moreno MJ, Jaramillo S, Pereira Gallardo S, Vallejo A, Mora M, García-Escudero A, Amérigo J, González-Cámpora R.
    Pathol Res Pract; 2012 Feb 15; 208(2):74-81. PubMed ID: 22197035
    [Abstract] [Full Text] [Related]

  • 38. Strong PDGFRA positivity is seen in GISTs but not in other intra-abdominal mesenchymal tumors: Immunohistochemical and mutational analyses.
    Peterson MR, Piao Z, Weidner N, Yi ES.
    Appl Immunohistochem Mol Morphol; 2006 Dec 15; 14(4):390-6. PubMed ID: 17122634
    [Abstract] [Full Text] [Related]

  • 39. Spectrum and prognostication of KIT and PDGFRA mutation in gastrointestinal stromal tumors.
    Tzen CY, Wang MN, Mau BL.
    Eur J Surg Oncol; 2008 May 15; 34(5):563-8. PubMed ID: 17532173
    [Abstract] [Full Text] [Related]

  • 40. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours.
    Lasota J, Miettinen M.
    Histopathology; 2008 Sep 15; 53(3):245-66. PubMed ID: 18312355
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.